AstraZeneca On Bridging The Gap Between Accelerated Approval And HTA Requirements

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media. © 2017 Health […]

Treatments for Old World cutaneous leishmaniasis

Background Old World cutaneus leishmaniasis (OWCL) is an infection caused by the Leishmania parasite, which is passed onto humans by the bite of sandflies. It is a serious skin disease associated with a broad range of signs, symptoms, and degrees of severity. We wanted to assess the competence and safety […]

NQF Elects New Leadership, Members

The National Quality Forum’s (NQF) Board of Directors elected Jim Chase, senior advisor for the Network for Regional Healthcare Improvement, and Jonathan Perlin, president of clinical services and Chief Medical Officer for the Hospital Corporation of America as its new chair and vice chair, respectively. The NQF board also appointed […]

Zuclopenthixol dihydrochloride for schizophrenia

We included 20 trials, randomising 1850 participants. Data were reported for 12 comparisons, predominantly for the short term (up to 12 weeks) and inpatient populations. Overall risk of bias for included studies was low to unclear. Data were unavailable for many of our pre-stated outcomes of interest. No data were […]

Music therapy for depression

We included in this review nine studies involving a total of 421 participants, 411 of whom were included in the meta-analysis examining short-term effects of music therapy for depression. Concerning primary outcomes, we found moderate-quality evidence of large effects favouring music therapy and TAU over TAU alone for both clinician-rated […]

Early erythropoiesis-stimulating agents in preterm or low birth weight infants

This updated review includes 34 studies enrolling 3643 infants. All analyses compared ESAs versus a control consisting of placebo or no treatment. Early ESAs reduced the risk of ‘use of one or more [red blood cell] RBC transfusions’ (typical risk ratio (RR) 0.79, 95% confidence interval (CI) 0.74 to 0.85; […]

Are there any smoking cessation programmes that can help adolescents to stop smoking?

Background Worldwide, between 80,000 and 100,000 young people start smoking every day. Many adolescent tobacco programmes focus on preventing teenagers from starting to smoke, but some programmes have been aimed at helping those teenagers who are already smoking to quit. We set out to investigate whether these programmes can help […]

The Recommended Dose: Episode 5 with Paul Glasziou

Episode 5: Professor Paul GlasziouProfessor of Evidence-Based Medicine, Bond University, Robina, Queensland, Australia;and part-time General Practitioner Paul Glasziou (aka The Surfing Professor) joins Ray this week to share insights from his stellar career as both a family doctor in Brisbane and a global evidence guru at Oxford and Bond Universities. […]

Article Spotlights Need for Evidence-Based HTA for Off-Patent Products

An article published in Value Health Regional Issues takes a look at an initiative to create an evidence-based health technology assessment (HTA) method for off-patent products. The article’s authors were: Diana Brixner, Nikos Maniadakis, Zoltán Kaló, Shanlian Hu, Jie Shen and Kalman Wijaya. “Because many emerging countries are heading toward […]

Artificial Intelligence in the Pharma Industry   New Syndicated Report

Artificial Intelligence (AI) can positively disrupt many of pharma’s business areas and processes. From smarter drug candidate identification and repurposing older products to faster clinical trial recruitment and improved clinician/patient education and support. But pharma remains dangerously behind the AI curve and advocates say the time is now for pharma […]

ICER Weekly View 11-17-17

From the desk of Mitchell Stein Good morning.  The health policy community lost a titan this week.  Uwe Reinhardt, an economist whose insights were only matched by his wit, passed away.  If you’re involved in health care, even if you don’t realize it, you’ve come across his ideas.  Here’s one […]

Nu stärks brukarnas inflytande i nio myndigheter

den 17 november 2017 Nio myndigheter upprättar ett samarbete för att bättre ta vara på patienters och brukares erfarenheter. I förlängningen kommer dessa att få större möjlighet att påverka prioriteringar av morgondagens forskning och kunskapsstöd till vård och omsorg. Stärkt patient- och brukarinflytande är en av de prioriterade frågorna för […]

Nu stärks brukarnas inflytande i nio myndigheter

Stärkt patient- och brukarinflytande är en av de prioriterade frågorna för Rådet för styrning med kunskap. Därför tillsattes förra året en arbetsgrupp med representanter för samtliga de nio myndigheter som ingår i Rådet, bland annat Folkhälsomyndigheten. Gruppen tog då även hjälp av representanter för fem stora patientorganisationer och intresseföreningar. Och […]

test for cons ()

Pre Noc Submission NOC Date Submission Date (Target Date) Prioritization Requested Stakeholder Input Deadline (target date based on target submission date) ‡ Check-point meeting (target date) pERC Meeting (target date) Initial Recommendation Issued (target date) Feedback Deadline (target date) ‡ pERC Reconsideration Meeting (target date) Final Recommendation Issued (target date) […]